Global and Japan PCR and NGS-Based Molecular Diagnostics Market Size, Status and Forecast 2024-2031

Report ID: 1023496 | Published Date: Oct 2024 | No. of Page: 108 | Base Year: 2023 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Biomarker Discovery
        1.2.3 Blood Sample Testig
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global PCR and NGS-Based Molecular Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Academics/Research Institutions
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global PCR and NGS-Based Molecular Diagnostics Market Perspective (2016-2027)
    2.2 PCR and NGS-Based Molecular Diagnostics Growth Trends by Regions
        2.2.1 PCR and NGS-Based Molecular Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 PCR and NGS-Based Molecular Diagnostics Historic Market Share by Regions (2016-2021)
        2.2.3 PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Regions (2022-2027)
    2.3 PCR and NGS-Based Molecular Diagnostics Industry Dynamic
        2.3.1 PCR and NGS-Based Molecular Diagnostics Market Trends
        2.3.2 PCR and NGS-Based Molecular Diagnostics Market Drivers
        2.3.3 PCR and NGS-Based Molecular Diagnostics Market Challenges
        2.3.4 PCR and NGS-Based Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top PCR and NGS-Based Molecular Diagnostics Players by Revenue
        3.1.1 Global Top PCR and NGS-Based Molecular Diagnostics Players by Revenue (2016-2021)
        3.1.2 Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Players (2016-2021)
    3.2 Global PCR and NGS-Based Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by PCR and NGS-Based Molecular Diagnostics Revenue
    3.4 Global PCR and NGS-Based Molecular Diagnostics Market Concentration Ratio
        3.4.1 Global PCR and NGS-Based Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by PCR and NGS-Based Molecular Diagnostics Revenue in 2020
    3.5 PCR and NGS-Based Molecular Diagnostics Key Players Head office and Area Served
    3.6 Key Players PCR and NGS-Based Molecular Diagnostics Product Solution and Service
    3.7 Date of Enter into PCR and NGS-Based Molecular Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 PCR and NGS-Based Molecular Diagnostics Breakdown Data by Type
    4.1 Global PCR and NGS-Based Molecular Diagnostics Historic Market Size by Type (2016-2021)
    4.2 Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Type (2022-2027)

5 PCR and NGS-Based Molecular Diagnostics Breakdown Data by Application
    5.1 Global PCR and NGS-Based Molecular Diagnostics Historic Market Size by Application (2016-2021)
    5.2 Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America PCR and NGS-Based Molecular Diagnostics Market Size (2016-2027)
    6.2 North America PCR and NGS-Based Molecular Diagnostics Market Size by Type
        6.2.1 North America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2016-2021)
        6.2.2 North America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2022-2027)
        6.2.3 North America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2016-2027)
    6.3 North America PCR and NGS-Based Molecular Diagnostics Market Size by Application
        6.3.1 North America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2016-2021)
        6.3.2 North America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2022-2027)
        6.3.3 North America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2016-2027)
    6.4 North America PCR and NGS-Based Molecular Diagnostics Market Size by Country
        6.4.1 North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2016-2021)
        6.4.2 North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe PCR and NGS-Based Molecular Diagnostics Market Size (2016-2027)
    7.2 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Type
        7.2.1 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Type (2016-2021)
        7.2.2 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Type (2022-2027)
        7.2.3 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Type (2016-2027)
    7.3 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Application
        7.3.1 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Application (2016-2021)
        7.3.2 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Application (2022-2027)
        7.3.3 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Application (2016-2027)
    7.4 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country
        7.4.1 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2016-2021)
        7.4.2 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size (2016-2027)
    8.2 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Type
        8.2.1 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Type (2016-2027)
    8.3 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Application
        8.3.1 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Application (2016-2027)
    8.4 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Region
        8.4.1 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America PCR and NGS-Based Molecular Diagnostics Market Size (2016-2027)
    9.2 Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Type
        9.2.1 Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2016-2021)
        9.2.2 Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2022-2027)
        9.2.3 Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2016-2027)
    9.3 Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Application
        9.3.1 Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2016-2021)
        9.3.2 Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2022-2027)
        9.3.3 Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2016-2027)
    9.4 Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country
        9.4.1 Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2016-2021)
        9.4.2 Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size (2016-2027)
    10.2 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Type
        10.2.1 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Type (2016-2027)
    10.3 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Application
        10.3.1 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Application (2016-2027)
    10.4 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country
        10.4.1 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Thermofisher
        11.1.1 Thermofisher Company Details
        11.1.2 Thermofisher Business Overview
        11.1.3 Thermofisher PCR and NGS-Based Molecular Diagnostics Introduction
        11.1.4 Thermofisher Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
        11.1.5 Thermofisher Recent Development
    11.2 Illumine
        11.2.1 Illumine Company Details
        11.2.2 Illumine Business Overview
        11.2.3 Illumine PCR and NGS-Based Molecular Diagnostics Introduction
        11.2.4 Illumine Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
        11.2.5 Illumine Recent Development
    11.3 Paragon Genomics
        11.3.1 Paragon Genomics Company Details
        11.3.2 Paragon Genomics Business Overview
        11.3.3 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Introduction
        11.3.4 Paragon Genomics Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
        11.3.5 Paragon Genomics Recent Development
    11.4 Roche
        11.4.1 Roche Company Details
        11.4.2 Roche Business Overview
        11.4.3 Roche PCR and NGS-Based Molecular Diagnostics Introduction
        11.4.4 Roche Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
        11.4.5 Roche Recent Development
    11.5 Qiagen
        11.5.1 Qiagen Company Details
        11.5.2 Qiagen Business Overview
        11.5.3 Qiagen PCR and NGS-Based Molecular Diagnostics Introduction
        11.5.4 Qiagen Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
        11.5.5 Qiagen Recent Development
    11.6 Bioo Scientific
        11.6.1 Bioo Scientific Company Details
        11.6.2 Bioo Scientific Business Overview
        11.6.3 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Introduction
        11.6.4 Bioo Scientific Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
        11.6.5 Bioo Scientific Recent Development
    11.7 Agilent
        11.7.1 Agilent Company Details
        11.7.2 Agilent Business Overview
        11.7.3 Agilent PCR and NGS-Based Molecular Diagnostics Introduction
        11.7.4 Agilent Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
        11.7.5 Agilent Recent Development
    11.8 Pillar Biosciences
        11.8.1 Pillar Biosciences Company Details
        11.8.2 Pillar Biosciences Business Overview
        11.8.3 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Introduction
        11.8.4 Pillar Biosciences Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
        11.8.5 Pillar Biosciences Recent Development
    11.9 LC-Bio Technologies (Hangzhou) CO. LTD.
        11.9.1 LC-Bio Technologies (Hangzhou) CO. LTD. Company Details
        11.9.2 LC-Bio Technologies (Hangzhou) CO. LTD. Business Overview
        11.9.3 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Introduction
        11.9.4 LC-Bio Technologies (Hangzhou) CO. LTD. Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
        11.9.5 LC-Bio Technologies (Hangzhou) CO. LTD. Recent Development
    11.10 iGen Technologies
        11.10.1 iGen Technologies Company Details
        11.10.2 iGen Technologies Business Overview
        11.10.3 iGen Technologies PCR and NGS-Based Molecular Diagnostics Introduction
        11.10.4 iGen Technologies Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
        11.10.5 iGen Technologies Recent Development
    11.11 Burning Rock
        11.11.1 Burning Rock Company Details
        11.11.2 Burning Rock Business Overview
        11.11.3 Burning Rock PCR and NGS-Based Molecular Diagnostics Introduction
        11.11.4 Burning Rock Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
        11.11.5 Burning Rock Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Biomarker Discovery
    Table 3. Key Players of Blood Sample Testig
    Table 4. Key Players of Others
    Table 5. Global PCR and NGS-Based Molecular Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global PCR and NGS-Based Molecular Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global PCR and NGS-Based Molecular Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global PCR and NGS-Based Molecular Diagnostics Market Share by Regions (2016-2021)
    Table 9. Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global PCR and NGS-Based Molecular Diagnostics Market Share by Regions (2022-2027)
    Table 11. PCR and NGS-Based Molecular Diagnostics Market Trends
    Table 12. PCR and NGS-Based Molecular Diagnostics Market Drivers
    Table 13. PCR and NGS-Based Molecular Diagnostics Market Challenges
    Table 14. PCR and NGS-Based Molecular Diagnostics Market Restraints
    Table 15. Global PCR and NGS-Based Molecular Diagnostics Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global PCR and NGS-Based Molecular Diagnostics Market Share by Players (2016-2021)
    Table 17. Global Top PCR and NGS-Based Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PCR and NGS-Based Molecular Diagnostics as of 2020)
    Table 18. Ranking of Global Top PCR and NGS-Based Molecular Diagnostics Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by PCR and NGS-Based Molecular Diagnostics Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players PCR and NGS-Based Molecular Diagnostics Product Solution and Service
    Table 22. Date of Enter into PCR and NGS-Based Molecular Diagnostics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global PCR and NGS-Based Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Type (2016-2021)
    Table 26. Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global PCR and NGS-Based Molecular Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Application (2016-2021)
    Table 30. Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Thermofisher Company Details
    Table 63. Thermofisher Business Overview
    Table 64. Thermofisher PCR and NGS-Based Molecular Diagnostics Product
    Table 65. Thermofisher Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 66. Thermofisher Recent Development
    Table 67. Illumine Company Details
    Table 68. Illumine Business Overview
    Table 69. Illumine PCR and NGS-Based Molecular Diagnostics Product
    Table 70. Illumine Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 71. Illumine Recent Development
    Table 72. Paragon Genomics Company Details
    Table 73. Paragon Genomics Business Overview
    Table 74. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Product
    Table 75. Paragon Genomics Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 76. Paragon Genomics Recent Development
    Table 77. Roche Company Details
    Table 78. Roche Business Overview
    Table 79. Roche PCR and NGS-Based Molecular Diagnostics Product
    Table 80. Roche Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 81. Roche Recent Development
    Table 82. Qiagen Company Details
    Table 83. Qiagen Business Overview
    Table 84. Qiagen PCR and NGS-Based Molecular Diagnostics Product
    Table 85. Qiagen Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 86. Qiagen Recent Development
    Table 87. Bioo Scientific Company Details
    Table 88. Bioo Scientific Business Overview
    Table 89. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Product
    Table 90. Bioo Scientific Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 91. Bioo Scientific Recent Development
    Table 92. Agilent Company Details
    Table 93. Agilent Business Overview
    Table 94. Agilent PCR and NGS-Based Molecular Diagnostics Product
    Table 95. Agilent Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 96. Agilent Recent Development
    Table 97. Pillar Biosciences Company Details
    Table 98. Pillar Biosciences Business Overview
    Table 99. Pillar Biosciences Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 100. Pillar Biosciences Recent Development
    Table 101. LC-Bio Technologies (Hangzhou) CO. LTD. Company Details
    Table 102. LC-Bio Technologies (Hangzhou) CO. LTD. Business Overview
    Table 103. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Product
    Table 104. LC-Bio Technologies (Hangzhou) CO. LTD. Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 105. LC-Bio Technologies (Hangzhou) CO. LTD. Recent Development
    Table 106. iGen Technologies Company Details
    Table 107. iGen Technologies Business Overview
    Table 108. iGen Technologies PCR and NGS-Based Molecular Diagnostics Product
    Table 109. iGen Technologies Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 110. iGen Technologies Recent Development
    Table 111. Burning Rock Company Details
    Table 112. Burning Rock Business Overview
    Table 113. Burning Rock PCR and NGS-Based Molecular Diagnostics Product
    Table 114. Burning Rock Revenue in PCR and NGS-Based Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 115. Burning Rock Recent Development
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global PCR and NGS-Based Molecular Diagnostics Market Share by Type: 2020 VS 2027
    Figure 2. Biomarker Discovery Features
    Figure 3. Blood Sample Testig Features
    Figure 4. Others Features
    Figure 5. Global PCR and NGS-Based Molecular Diagnostics Market Share by Application: 2020 VS 2027
    Figure 6. Hospitals Case Studies
    Figure 7. Academics/Research Institutions Case Studies
    Figure 8. Others Case Studies
    Figure 9. PCR and NGS-Based Molecular Diagnostics Report Years Considered
    Figure 10. Global PCR and NGS-Based Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global PCR and NGS-Based Molecular Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global PCR and NGS-Based Molecular Diagnostics Market Share by Regions: 2020 VS 2027
    Figure 13. Global PCR and NGS-Based Molecular Diagnostics Market Share by Regions (2022-2027)
    Figure 14. Global PCR and NGS-Based Molecular Diagnostics Market Share by Players in 2020
    Figure 15. Global Top PCR and NGS-Based Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PCR and NGS-Based Molecular Diagnostics as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by PCR and NGS-Based Molecular Diagnostics Revenue in 2020
    Figure 17. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Type (2016-2021)
    Figure 18. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Type (2022-2027)
    Figure 19. North America PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America PCR and NGS-Based Molecular Diagnostics Market Share by Type (2016-2027)
    Figure 21. North America PCR and NGS-Based Molecular Diagnostics Market Share by Application (2016-2027)
    Figure 22. North America PCR and NGS-Based Molecular Diagnostics Market Share by Country (2016-2027)
    Figure 23. United States PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe PCR and NGS-Based Molecular Diagnostics Market Share by Type (2016-2027)
    Figure 27. Europe PCR and NGS-Based Molecular Diagnostics Market Share by Application (2016-2027)
    Figure 28. Europe PCR and NGS-Based Molecular Diagnostics Market Share by Country (2016-2027)
    Figure 29. Germany PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Share by Region (2016-2027)
    Figure 39. China PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America PCR and NGS-Based Molecular Diagnostics Market Share by Type (2016-2027)
    Figure 47. Latin America PCR and NGS-Based Molecular Diagnostics Market Share by Application (2016-2027)
    Figure 48. Latin America PCR and NGS-Based Molecular Diagnostics Market Share by Country (2016-2027)
    Figure 49. Mexico PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Share by Country (2016-2027)
    Figure 55. Turkey PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Thermofisher Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
    Figure 59. Illumine Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
    Figure 60. Paragon Genomics Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
    Figure 61. Roche Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
    Figure 62. Qiagen Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
    Figure 63. Bioo Scientific Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
    Figure 64. Agilent Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
    Figure 65. Pillar Biosciences Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
    Figure 66. LC-Bio Technologies (Hangzhou) CO. LTD. Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
    Figure 67. iGen Technologies Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
    Figure 68. Burning Rock Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2016-2021)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Thermofisher
Illumine
Paragon Genomics
Roche
Qiagen
Bioo Scientific
Agilent
Pillar Biosciences
LC-Bio Technologies (Hangzhou) CO. LTD.
iGen Technologies
Burning Rock
Frequently Asked Questions
PCR and NGS-Based Molecular Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
PCR and NGS-Based Molecular Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
PCR and NGS-Based Molecular Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Buna-N Rubber

Buna-N Rubber market is segmented by region (country), players, by Type, and by Application. Play ... Read More